Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGO
4251
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $19K | ﹤0.01% |
1,375
-2,958
| -68% | -$47K |
|
|
PZN
4252
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $19K | ﹤0.01% |
2,745
-1,867
| -40% | -$12.7K |
|
|
ENDP
4253
DELISTED
Endo International plc
ENDP
| $19K | ﹤0.01% |
43,086
-324,631
| -88% | -$412K |
|
|
ARIS
4254
DELISTED
Aris Water Solutions
ARIS
| $18K | ﹤0.01% |
1,105
-2,056
| -65% | -$37.3K |
|
4255
Chunghwa Telecom
CHT
$33B
| $18K | ﹤0.01% |
+431
| New | +$18.6K |
|
4256
Cue Biopharma
CUE
$114M
| $18K | ﹤0.01% |
240
-167
| -41% | -$19.5K |
|
4257
Harrow
HROW
$1.51B
| $18K | ﹤0.01% |
2,467
| – | – |
|
4258
Merchants Bancorp
MBIN
$2.49B
| $18K | ﹤0.01% |
790
-1,680
| -68% | -$41K |
|
4259
Omega Flex
OFLX
$312M
| $18K | ﹤0.01% |
164
-355
| -68% | -$40.3K |
|
4260
OneWater Marine
ONEW
$201M
| $18K | ﹤0.01% |
556
-1,229
| -69% | -$41K |
|
|
RYZ
4261
Ryerson Holding Corp
RYZ
$1.46B
| $18K | ﹤0.01% |
833
-1,916
| -70% | -$60.1K |
|
4262
Vertex
VERX
$1.94B
| $18K | ﹤0.01% |
1,612
-52
| -3% | -$658 |
|
4263
Vishay Precision Group
VPG
$914M
| $18K | ﹤0.01% |
623
-1,454
| -70% | -$44.5K |
|
|
NEUE
4264
DELISTED
NeueHealth
NEUE
| $18K | ﹤0.01% |
121
-404
| -77% | -$58.8K |
|
|
ORGS
4265
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $18K | ﹤0.01% |
728
| – | – |
|
|
AVX
4266
Avax One Technology Ltd
AVX
$26.4M
| – | – |
0
| – | – |
|
4267
Bridgewater Bancshares
BWB
$603M
| $17K | ﹤0.01% |
1,035
-2,385
| -70% | -$38.3K |
|
4268
Five Star Bancorp
FSBC
$1.13B
| $17K | ﹤0.01% |
632
-1,391
| -69% | -$36.8K |
|
|
GBIO
4269
DELISTED
Generation Bio
GBIO
| $17K | ﹤0.01% |
253
-476
| -65% | -$31.1K |
|
4270
Greif Class B
GEF.B
$4.21B
| $17K | ﹤0.01% |
270
-713
| -73% | -$42.6K |
|
|
HUT
4271
Hut 8
HUT
$10.9B
| $17K | ﹤0.01% |
2,560
-106
| -4% | -$1.58K |
|
4272
First Internet Bancorp
INBK
$255M
| $17K | ﹤0.01% |
454
-1,055
| -70% | -$40.6K |
|
4273
Magnachip Semiconductor
MX
$145M
| $17K | ﹤0.01% |
1,200
+1,007
| +522% | +$17.3K |
|
4274
PLAYSTUDIOS Inc
MYPS
$90.1M
| $17K | ﹤0.01% |
+3,977
| New | +$21.6K |
|
4275
Neuropace
NPCE
$506M
| $17K | ﹤0.01% |
3,401
-1,152
| -25% | -$7.61K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.